top of page
Lucid

R01 (NIH/NIDDK) grant application selected for funding!

  • hassanalaliphd
  • Feb 2, 2023
  • 1 min read

The molecular mechanisms underlying nephrotic syndrome (NS) are unknown. In this three-way collaboration between Duke University (primary), University of Miami, and University of Michigan, we will examine the role of genetic defects in RCAN1 and other genes in the calcineurin signaling pathways in the pathogenesis of NS, identify predictors of response to calcineurin inhibitors, and new therapeutic targets for NS. We are excited to bring the drug discovery technologies of the Ali lab to bear on nephrotic syndrome with world-class experts in this area!

 
 
 

Recent Posts

See All
Feature article in InventUM

Full article: https://news.med.miami.edu/dr-hassan-al-alis-contribution-to-the-evolving-landscape-of-drug-discovery/ Dr. Hassan Al Ali’s Contribution to the Evolving Landscape of Drug Discovery Summar

 
 
 
New DoD Funding

The Zeier and Ali labs received a DoD Therapeutic Idea Award. The goal of the project is to evaluate whether the spinal cord injury drug...

 
 
 

Comments


Office, LPLC 5-17

1095 NW 14th Terrace

Miami FL-33136

​Lab, The Miami Project To Cure Paralysis

Lois Pope LIFE Center #426

1095 NW 14th Terrace

Miami FL-33136

​Drug Discovery Core, The Miami Project To Cure Paralysis

Lois Pope LIFE Center #410

1095 NW 14th Terrace

Miami FL-33136

bottom of page